Pfizers acquisition of Metsera, the explosion of Lillys market cap, and the federal governments push to expand access to obesity treatment are not disconnected headlines
Prog Biomaterials (2022)
Retatrutide Triple Hormone Receptor Agonist: Mechanism, Evidence, and UK Status Retatrutide, the investigational triple hormone receptor agonist peptide, represents one of the most closely watched developments in obesity medicine
Sleep Apnea is now being treated with tirzepatide (FDA approved)
Betsy Dovec, prescribed a low dose of the drug Zepbound, even though Woodard's body mass index didn't technically classify her as overweight
Ten days before I met him at his home in British Columbia, Dave Asprey went to a clinic in Park City, Utah, where a surgeon harvested half a liter of bone marrow from his hips, filtered out the stem cells, and injected them into every joint in his body